Company registration number 09524503 (England and Wales)
PHARMACIERGE TECHNOLOGY LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
PAGES FOR FILING WITH REGISTRAR
PHARMACIERGE TECHNOLOGY LIMITED
COMPANY INFORMATION
Directors
Mr L A Ungar
Mr E G Ungar
Mr R D L Ungar
Secretary
Mr E G Ungar
Company number
09524503
Registered office
3rd Floor
Hathaway House
Popes Drive
London
N3 1QF
Auditor
F M C B
3rd Floor Hathaway House
Popes Drive
Finchley
London
N3 1QF
Business address
43A Wimpole Street
London
W1G 8AQ
Bankers
HSBC Bank plc
Lion House
25 Islington High Street
London
N1 9LJ
PHARMACIERGE TECHNOLOGY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
PHARMACIERGE TECHNOLOGY LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2024
30 September 2024
- 1 -
2024
2023
Notes
£
£
£
£
Current assets
Debtors
3
3,517
4,523
Cash at bank and in hand
1,431
208,302
4,948
212,825
Creditors: amounts falling due within one year
4
(2,286,033)
(2,160,502)
Net current liabilities
(2,281,085)
(1,947,677)
Capital and reserves
Called up share capital
1
1
Profit and loss reserves
(2,281,086)
(1,947,678)
Total equity
(2,281,085)
(1,947,677)
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 25 June 2025 and are signed on its behalf by:
Mr E G Ungar
Mr R D L Ungar
Director
Director
Company registration number 09524503 (England and Wales)
PHARMACIERGE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 2 -
1
Accounting policies
Company information
Pharmacierge Technology Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3rd Floor, Hathaway House, Popes Drive, Finchley, London, N3 1QF.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate support from its other group companies to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
1.4
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.5
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences that have originated but not reversed at the balance sheet date.
PHARMACIERGE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 3 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2024
2023
Number
Number
Total
3
3
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
3,517
4,523
4
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
33,642
43,685
Amounts owed to group undertakings
2,206,080
2,115,717
Other creditors
46,311
1,100
2,286,033
2,160,502
5
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 30 September 2024 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Gavin Zeiderman BA(Hons) FCA
Statutory Auditor:
F M C B
Date of audit report:
26 June 2025
6
Parent company
The company is a wholly owned subsidiary of Pharmacierge Group Limited, a company registered in England and Wales and its registered office is 3rd Floor, Hathaway House, Popes Drive, London, N3 1QF.
PHARMACIERGE TECHNOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
6
Parent company
(Continued)
- 4 -
The ultimate controlling party is Pharmacierge Group Limited.